PuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles

Bulletin Express
10/31

PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.

The Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.

According to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10